US HB2821 | 2025-2026 | 119th Congress
Status
Sponsorship: Bipartisan Bill
Status: Engrossed on July 21 2026 - 50% progression
Action: 2026-07-21 - Received in the Senate.
Text: Latest bill text (Engrossed) [PDF]
Status: Engrossed on July 21 2026 - 50% progression
Action: 2026-07-21 - Received in the Senate.
Text: Latest bill text (Engrossed) [PDF]
Summary
To require the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to publish a final rule relating to nonclinical testing methods.
Title
FDA Modernization Act 3.0
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2026-07-21 | Senate | Received in the Senate. |
| 2026-07-20 | House | Motion to reconsider laid on the table Agreed to without objection. |
| 2026-07-20 | House | On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H4639) |
| 2026-07-20 | House | DEBATE - The House proceeded with forty minutes of debate on H.R. 2821. |
| 2026-07-20 | House | Considered under suspension of the rules. (consideration: CR H4639-4640) |
| 2026-07-20 | House | Mr. Guthrie moved to suspend the rules and pass the bill. |
| 2026-06-18 | House | Placed on the Union Calendar, Calendar No. 614. |
| 2026-06-18 | House | Reported by the Committee on Energy and Commerce. H. Rept. 119-706. |
| 2026-05-21 | House | Ordered to be Reported by the Yeas and Nays: 44 - 0. |
| 2026-05-21 | House | Committee Consideration and Mark-up Session Held |
| 2026-05-13 | House | Forwarded by Subcommittee to Full Committee by Voice Vote. |
| 2026-05-13 | House | Subcommittee Consideration and Mark-up Session Held |
| 2026-04-10 | House | Referred to the Subcommittee on Health. |
| 2025-04-10 | House | Referred to the House Committee on Energy and Commerce. |
| 2025-04-10 | House | Introduced in House |
Same As/Similar To
SB355 (Same As) 2025-12-17 - Held at the desk.
